Pathology: mML - L1 - all population; mML - L1 - BRAF mutant; mML - L1 - BRAF wild;
mML - L1 - all population | mML - L1 - BRAF mutant | mML - L1 - BRAF wild | |||||
CheckMate 069 (all population), 2015 | CheckMate 067 (NI vs I ; all population), 2015 | CheckMate 067 (NI vs N) EXPLORATORY, 2015 | RELATIVITY-047, 0 | CheckMate 069 (BRAF mutant) EXPLORATORY, 2015 | CheckMate 069 (BRAF wild type), 2015 | ||
nivolumab plus ipilimumab | 5 | T1 | T1 | T1 | T1 | T1 | |
relatlimab plus nivolumab | 1 | T1 | |||||
nivolumab alone | 0 | T0 | T0 | ||||
ipilimumab alone | 0 | T0 | T0 | T0 | T0 |